These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37931350)

  • 1. Average annual cost of Parkinson's disease in a Brazilian multiethnic population.
    Bovolenta TM; Schumacher-Schuh AF; Santos-Lobato BLD; Godeiro Júnior CO; Silva DJD; Nicaretta D; Barbosa ER; Cardoso FEC; Della Coletta MV; Braga Neto P; Cury RG; Tumas V; Felicio AC
    Parkinsonism Relat Disord; 2023 Dec; 117():105897. PubMed ID: 37931350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Average annual cost of Parkinson's disease in São Paulo, Brazil, with a focus on disease-related motor symptoms.
    Bovolenta TM; de Azevedo Silva SMC; Saba RA; Borges V; Ferraz HB; Felicio AC
    Clin Interv Aging; 2017; 12():2095-2108. PubMed ID: 29276379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Parkinson's disease among Filipino patients seen at a public tertiary hospital in Metro Manila.
    Prado M; Jamora RD
    J Clin Neurosci; 2020 Apr; 74():41-46. PubMed ID: 31983646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of Parkinson's disease in Singapore.
    Zhao YJ; Tan LC; Li SC; Au WL; Seah SH; Lau PN; Luo N; Wee HL
    Eur J Neurol; 2011 Mar; 18(3):519-26. PubMed ID: 20840378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of illness in a Russian cohort of patients with Parkinson's disease.
    Winter Y; von Campenhausen S; Popov G; Reese JP; Klotsche J; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A
    Pharmacoeconomics; 2009; 27(7):571-84. PubMed ID: 19663528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.
    Winter Y; Balzer-Geldsetzer M; Spottke A; Reese JP; Baum E; Klotsche J; Rieke J; Simonow A; Eggert K; Oertel WH; Dodel R
    Eur J Neurol; 2010 Sep; 17(9):1156-1163. PubMed ID: 20345926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of illness and its predictors for Parkinson's disease in Germany.
    Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
    Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability and use of healthcare resources in Brazilian patients with Parkinson's disease.
    Vargas AP; Carod-Artal FJ; Nunes SV; Melo M
    Disabil Rehabil; 2008; 30(14):1055-62. PubMed ID: 18953751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
    Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
    Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States.
    Martinez-Martin P; Macaulay D; Jalundhwala YJ; Mu F; Ohashi E; Marshall T; Sail K
    Mov Disord; 2019 Feb; 34(2):236-245. PubMed ID: 30589953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
    Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary.
    Tamás G; Gulácsi L; Bereczki D; Baji P; Takáts A; Brodszky V; Péntek M
    PLoS One; 2014; 9(9):e107704. PubMed ID: 25229404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impact of Parkinson's disease.
    Findley LJ
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S8-S12. PubMed ID: 17702630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].
    Dodel RC; Singer M; Köhne-Volland R; Selzer R; Scholz W; Rathay B; Oertel WH
    Nervenarzt; 1997 Dec; 68(12):978-84. PubMed ID: 9465341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost of illness and health service patterns in Morbus Parkinson in Austria].
    von Campenhausen S; Winter Y; Gasser J; Seppi K; Reese JP; Pfeiffer KP; Geiger-Gritsch S; Bötzel K; Siebert U; Oertel WH; Dodel R; Poewe W
    Wien Klin Wochenschr; 2009; 121(17-18):574-82. PubMed ID: 19890747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the direct and indirect costs associated with Parkinson's disease.
    Rodríguez-Blázquez C; Forjaz MJ; Lizán L; Paz S; Martínez-Martín P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):889-911. PubMed ID: 26511768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.
    Carod-Artal FJ; Mesquita HM; Ziomkowski S; Martinez-Martin P
    Parkinsonism Relat Disord; 2013 Nov; 19(11):943-8. PubMed ID: 23831481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.